{"organizations": [], "uuid": "88d893e5b6a8e4ecf650923ec28c64300d1b2b31", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180518.html", "section_title": "Archive News &amp; Video for Friday, 18 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-parallax-health-sciences-says-roxs/brief-parallax-health-sciences-says-roxsan-filed-chapter-7-petition-idUSFWN1SP0UI", "country": "US", "domain_rank": 408, "title": "BRIEF-Parallax Health Sciences Says Roxsan Filed Chapter 7 Petition", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.272, "site_type": "news", "published": "2018-05-19T02:52:00.000+03:00", "replies_count": 0, "uuid": "88d893e5b6a8e4ecf650923ec28c64300d1b2b31"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-parallax-health-sciences-says-roxs/brief-parallax-health-sciences-says-roxsan-filed-chapter-7-petition-idUSFWN1SP0UI", "ord_in_thread": 0, "title": "BRIEF-Parallax Health Sciences Says Roxsan Filed Chapter 7 Petition", "locations": [], "entities": {"persons": [{"name": "roxsan", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-parallax health sciences says roxsan", "sentiment": "negative"}, {"name": "parallax health sciences inc", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 18 (Reuters) - Parallax Health Sciences Inc:\n* PARALLAX HEALTH SCIENCES - ON MAY 14, PURSUANT TO UNANIMOUS RESOLUTION OF BOARDS OF ROXSAN PHARMACY AND CO, ROXSAN FILED CHAPTER 7 PETITION\n* PARALLAX HEALTH SCIENCES INC - ROXSAN SEEKS TO DISCHARGE ABOUT $5 MILLION OF LIABILITIES OWED TO VARIOUS PARTIES INCLUDING MORE THAN $1 MILLION OWED TO CO\n* PARALLAX HEALTH SCIENCES INC - ROXSAN IS A WHOLLY-OWNED SUBSIDIARY OF CO- SEC FILING\n* PARALLAX HEALTH SCIENCES SAYS DUE TO ROXSAN CHAPTER 7 FILING, TIMOTHY YOO APPOINTED TRUSTEE ON MAY 15 Source text : ( bit.ly/2IUiUqM ) Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://bit.ly/2IUiUqM", "https://instagram.com/reuters/"], "published": "2018-05-19T02:52:00.000+03:00", "crawled": "2018-05-19T15:13:56.021+03:00", "highlightTitle": ""}